CLINICAL ROLE -
July 23rd 2025
June 18th 2025
Lenacapavir becomes the first and only twice-yearly option for HIV prevention.
March 20th 2025
As HIV treatment and prevention evolve, the use of long-acting injectables and their role in combating the HIV epidemic grows.
March 17th 2025
Data from conference abstracts and presentations indicate that both preexposure prophylaxis methods continue to demonstrate efficacy.
January 9th 2025
Pharmacists' accessibility and expertise in medication management make them ideal health care providers to discuss prevention strategies, medication adherence, and potential adverse effects.
Tenofovir Disoproxil Fumarate May Cause Kidney Damage in HIV
While nephrotoxicity associated with TDF has been well documented, prospective studies in HIV patients have been lacking.
Read More
Program Promotes Pre-Exposure Prophylaxis Use Among African American Women
African American women account for 62% of women diagnosed with HIV.
How Does Hiding HIV Infection Impact Adherence?
Study examines whether sharing HIV status has an impact on depression or anxiety symptoms.
Sharing HIV Status Not Found to Impact Adherence
HIV non-disclosure not found to have an adverse impact on depression or anxiety symptoms.
HIV Screening Among Mentally Ill Remains a Problem
Risky sexual behavior increases the rate of HIV transmission among at-risk populations.
Solving the Puzzle of AIDS-Related Dementia
Dementia is one of the most prevalent complications among patients with late-stage HIV.
FDA Allows Use of EU-Approved Drug for AIDS-Related Kaposi's Sarcoma
Sale of Panretin gel tubes approved in the United States due to a drug shortage as a result of a manufacturing issue.
Natural Antibodies May Boost Development of HIV Vaccine
Naturally-occurring antibodies that fight HIV open new avenues for research.
Understanding HIV Transmission Rates
Unprotected sexual exposure to HIV does not necessarily lead to infection.
How Does HIV Infection Impact Pregnancy Outcomes?
Benefits of ART for maternal health and prevention of perinatal transmission outweigh risks in mothers with HIV.
HIV Prevention Guidelines in Question
HIV treatment guidelines typically do not address specific characteristics for gay, bisexual, and men who have sex with men.
The Importance of Starting ART Early in HIV
National and global HIV guidelines recommend initiating antiretroviral therapy in all patients, regardless of CD4 count.
Vitamin D Deficiency May Influence Statin Efficacy in HIV Patients
Low baseline vitamin D deficiency may decrease the effectiveness of rosuvastatin in adults with HIV.
Trial Initiated for Long-Lasting Injectable PrEP to Block HIV Transmission
HIV drug trial will evaluate cabotegravir’s performance as a pre-exposure prophylaxis.
HIV Cure Could Cause Dangerous Adverse Events
Combination treatment methods to cure HIV may have harmful side effects.
Changing HIV Treatments to Overcome Resistance
HIV resistance may necessitate more costly therapies for third-line treatment.
HIV Combination Regimen Shows Promise
Two-drug combination with rilpivirine and dolutegravir demonstrated non-inferiority to other HIV regimens.
Counsel PrEP and ART Strategies in HIV-Serodiscordant Couples
Experts agree that integrated antiretroviral therapy (ART) for HIV-positive partners and time-limited pre-exposure prophylaxis (PrEP) for negative partners almost eliminates HIV transmission.
Top HIV News of 2016
Top HIV articles of the year on Specialty Pharmacy Times.
Risks Associated with Shock and Kill HIV Treatment Strategy
HIV hiding in the brain can cause damage to the patient.
Increased Access to Syringe Services May Reduce HIV Spread
Syringe services programs seek to halt the spread of HIV among injection drug users.
How Technology Can Overcome HIV Treatment Resistance
Lack of adherence to HIV medications can create resistance since the virus mutates quickly.
Dentist Office May Have Exposed Patients to HIV, Hepatitis
Pennsylvania health department recommends that patients be screened for HIV, and hepatitis B and C viruses.
New Antiretrovirals Show Promise Fighting HIV
Integrase inhibitors can reduce the HIV viral load to decrease transmission of the disease.
Progress Continues on Reducing HIV Incidence
Global HIV incidence rates drop in some African countries.
Why Do T Cells Turn Pathogenic?
Prior research suggested that T cells become pathogenic when they encounter specific dendritic cells in the lymph nodes.
HIV Treatment With ART May Need a New Strategy
Clinicians are able to prescribe ART more liberally for HIV because of its improved adverse event profile and wider array of available drugs.
When Should Antiretroviral Therapy be Initiated in HIV Treatment?
The recommended time to begin antiretroviral therapy has changed since it first arrived in the mid 90s for HIV.
Peer-Referral Strategies Improve HIV Diagnosis Rates
Peer referrals for testing can locate people with undiagnosed HIV better than health care providers.
How to Improve Portal Hypertension in Patients Coinfected With HIV-Hepatitis C
Portal hypertension creates problems in patients coinfected with HIV and hepatitis C virus.
